Literature DB >> 6826638

The consequences of chronic arsenic poisoning among Moselle wine growers. Pathoanatomical investigations of post-mortem examinations performed between 1960 and 1977.

H Lüchtrath.   

Abstract

From post-mortem examinations performed at the Pathology Institute at Koblenz, 163 cases of wine growers affected by chronic arsenic poisoning were analyzed. While a reduction could be seen in the number of cases of liver cirrhosis, the carcinoma rate was still high and even increased when compared to earlier reports. Lung cancers were identified in 66% of all wine growers affected and are thus the leading form of the skin were observed. A particular characteristic of amount of carcinomas or precarcinogenic alterations of arsenic carcinoma. However, nearly the same amount of carcinomas or precarcinogenic alterations of the skin were observed. A particular characteristic of cases. Among the multiple tumors, up to six different carcinomas were found. As arsenic is no longer detectable by toxicologic-chemical means the deposits of arsenic have been depleted and excreted long ago and so the diagnosis of chronic poisoning today depends on morphological changes of the skin (arsenic hyperkeratosis, melanosis and M. Bowen) which have been shown to be reliable. A comparison of our analysis with much more extensive material collected by the trade association supports our experience and the determined case rates. Furthermore modern theories on the carcinogenic action of arsenic, the question of the tumor latency and the relation of specific cancers to the poison are presented. In addition medical opinions on chronic arsenic poisoning are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6826638     DOI: 10.1007/bf00406929

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

1.  Trace elements in human tissue. I. Methods.

Authors:  I H TIPTON; M J COOK; R L STEINER; C A BOYE; H M PERRY; H A SCHROEDER
Journal:  Health Phys       Date:  1963-02       Impact factor: 1.316

2.  [Bronchial cancer of arsenic-poisoned vintagers].

Authors:  F ROTH
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1958

3.  Medical problems associated with arsenic exposure.

Authors:  C H Hine; S S Pinto; K W Nelson
Journal:  J Occup Med       Date:  1977-06

4.  Biological studies with arsenic; excretion and tissue localization.

Authors:  H S DUCOFF; W B NEAL
Journal:  Proc Soc Exp Biol Med       Date:  1948-12

5.  [Occupational arsenic lesions in vintagers].

Authors:  R Wolf
Journal:  Berufsdermatosen       Date:  1974-02

6.  Hazards of inorganic arsenic.

Authors:  D S Nurse
Journal:  Med J Aust       Date:  1978-01-28       Impact factor: 7.738

7.  Arsenic and cancer.

Authors:  R Jackson; J W Grainge
Journal:  Can Med Assoc J       Date:  1975-09-06       Impact factor: 8.262

8.  Effects of arsenic cell metabolism and cell proliferation: cytogenetic and biochemical studies.

Authors:  J Petres; D Baron; M Hagedorn
Journal:  Environ Health Perspect       Date:  1977-08       Impact factor: 9.031

9.  Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter.

Authors:  O Axelson; E Dahlgren; C D Jansson; S O Rehnlund
Journal:  Br J Ind Med       Date:  1978-02

10.  Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic.

Authors:  W P Tseng
Journal:  Environ Health Perspect       Date:  1977-08       Impact factor: 9.031

View more
  15 in total

1.  [Induction of urothelial carcinoma due to chronic arsenic ingestion? A occupational medicine-toxicological excursion].

Authors:  M Müller; A Böcher; A Buchter
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

2.  Inorganic arsenic compounds: are they carcinogenic, mutagenic, teratogenic?

Authors:  M Goldman; J C Dacre
Journal:  Environ Geochem Health       Date:  1991-12       Impact factor: 4.609

Review 3.  Pesticides and cancer risks in agriculture.

Authors:  O Axelson
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

4.  Arsenic-induced NFkappaB transactivation through Erks- and JNKs-dependent pathways in mouse epidermal JB6 cells.

Authors:  C Huang; J Li; M Ding; L Wang; X Shi; V Castranova; V Vallyathan; G Ju; M Costa
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

5.  Transactivation of RARE and GRE in the cellular response to arsenic.

Authors:  C Huang; J Li; M Ding; M Costa; V Castranova; V Vallyathan; G Ju; X Shi
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

Review 6.  Molecular mechanisms of arsenic carcinogenesis.

Authors:  Chuanshu Huang; Qingdong Ke; Max Costa; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

Review 7.  Occupational pesticide exposures and cancer risk: a review.

Authors:  Michael C R Alavanja; Matthew R Bonner
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2012       Impact factor: 6.393

8.  Age adjustment in ecological studies: using a study on arsenic ingestion and bladder cancer as an example.

Authors:  How-Ran Guo
Journal:  BMC Public Health       Date:  2011-10-20       Impact factor: 3.295

9.  Induction of human squamous cell-type carcinomas by arsenic.

Authors:  Victor D Martinez; Daiana D Becker-Santos; Emily A Vucic; Stephen Lam; Wan L Lam
Journal:  J Skin Cancer       Date:  2011-12-06

10.  Comparative study of growth performance, nutrient digestibility, and ruminal and fecal bacterial community between yaks and cattle-yaks raised by stall-feeding.

Authors:  Qindan Dai; Jian Ma; Guang Cao; Rui Hu; Yixiao Zhu; Guangyang Li; Huawei Zou; Zhisheng Wang; Quanhui Peng; Bai Xue; Lizhi Wang
Journal:  AMB Express       Date:  2021-06-30       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.